These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19289328)

  • 1. Type B insulin resistance developing during interferon-alpha therapy.
    Daniel AL; Houlihan JL; Blum JS; Walsh JP
    Endocr Pract; 2009 Mar; 15(2):153-7. PubMed ID: 19289328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 1 diabetes mellitus with dual autoimmune mechanism related to pegylated interferon and ribavirin treatment for chronic HCV hepatitis.
    Popescu C; Popescu GA; Arama V
    J Gastrointestin Liver Dis; 2013 Mar; 22(1):101-4. PubMed ID: 23539399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trajectories of anti-islet autoantibodies before development of type 1 diabetes in interferon-treated hepatitis C patients. Case reports and a literature review.
    Nakamura K; Kawasaki E; Abiru N; Jo O; Fukushima K; Satoh T; Kuriya G; Kobayashi M; Kuwahara H; Yamasaki H; Ide T; Eguchi K
    Endocr J; 2010; 57(11):947-51. PubMed ID: 20805634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha.
    Eibl N; Gschwantler M; Ferenci P; Eibl MM; Weiss W; Schernthaner G
    Eur J Gastroenterol Hepatol; 2001 Mar; 13(3):295-8. PubMed ID: 11293453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoantibodies against islet cell antigens and type 1 diabetes after treatment with interferon-alpha].
    Schories M; Peters T; Rasenack J; Reincke M
    Dtsch Med Wochenschr; 2004 May; 129(20):1120-4. PubMed ID: 15143453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 1 diabetes mellitus provoked by peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C.
    Tanaka J; Sugimoto K; Shiraki K; Beppu T; Yoneda K; Fuke H; Yamamoto N; Ito K; Takei Y
    Intern Med; 2008; 47(8):747-9. PubMed ID: 18421192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late development of diabetes mellitus after interferon-alfa and ribavirin therapy for chronic hepatitis C: a case report.
    Radhakrishnan S; Upadhyay A; Mohan N; Dhar A; Walia HK; Zubaidi G
    Med Princ Pract; 2005; 14(4):281-3. PubMed ID: 15961942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onset of type 1 diabetes mellitus during peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C.
    Cozzolongo R; Betterle C; Fabris P; Paola Albergoni M; Lanzilotta E; Manghisi OG
    Eur J Gastroenterol Hepatol; 2006 Jun; 18(6):689-92. PubMed ID: 16702861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
    Ahmed MS; Wong CF; Shawki H; Kapoor N; Pandya BK
    Clin Nephrol; 2008 Apr; 69(4):298-301. PubMed ID: 18397706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy.
    Bani-Sadr F; Carrat F; Pol S; Hor R; Rosenthal E; Goujard C; Morand P; Lunel-Fabiani F; Salmon-Ceron D; Piroth L; Pialoux G; Bentata M; Cacoub P; Perronne C;
    J Acquir Immune Defic Syndr; 2005 Sep; 40(1):47-52. PubMed ID: 16123681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies.
    Calise SJ; Zheng B; Hasegawa T; Satoh M; Isailovic N; Ceribelli A; Andrade LEC; Boylan K; Cavazzana I; Fritzler MJ; de la Torre IG; Hiepe F; Kohl K; Selmi C; Shoenfeld Y; Tincani A; Chan EKL;
    Clin Chem Lab Med; 2018 Sep; 56(10):1789-1798. PubMed ID: 29478040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS.
    Abi-Nassif S; Mark EJ; Fogel RB; Hallisey RK
    Chest; 2003 Jul; 124(1):406-10. PubMed ID: 12853555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Vogt-Koyanagi-Harada Disease by Interferon-Alpha and Ribavirin Treatment in Patients with Hepatitis C: A Case Report and Review of the Literature.
    Duan J; Wang Y; Liu D; Ma J
    Ocul Immunol Inflamm; 2019; 27(2):229-234. PubMed ID: 29023176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible myopathy during successful treatment with pegylated interferon and ribavirin for acute hepatitis C.
    Golstein PE; Delforge ML; Deviere J; Marcellin P
    J Viral Hepat; 2004 Mar; 11(2):183-6. PubMed ID: 14996354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C.
    Paraná R; Schinoni MI; de Freitas LA; Codes L; Cruz M; Andrade Z; Trepo C
    Liver Int; 2006 Nov; 26(9):1148-54. PubMed ID: 17032416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral insulin resistance during treatment of chronic hepatitis C with peguilated interferon plus ribavirin.
    Mello V; Cruz T; Nuñez G; Simões MT; Ney-Oliveira F; Braga H; Araújo C; Cunha S; Schinoni MI; Cruz M; Parana R
    J Med Virol; 2006 Nov; 78(11):1406-10. PubMed ID: 16998879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C: a randomized clinical trial.
    Bellobuono A; Mondazzi L; Tempini S; Silini E; Vicari F; Idéo G
    J Viral Hepat; 1997 May; 4(3):185-91. PubMed ID: 9181527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation.
    De Vera ME; Smallwood GA; Rosado K; Davis L; Martinez E; Sharma S; Stieber AC; Heffron TG
    Transplantation; 2001 Mar; 71(5):678-86. PubMed ID: 11292302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse hypertrichosis in the course of hepatitis C treatment by IFN-alpha and ribavirin.
    Misery L
    J Interferon Cytokine Res; 2002 Aug; 22(8):881-2. PubMed ID: 12396727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ischemic anterior optic neuropathy complicating interferon alpha-2a and ribavirin treatment for acute hepatitis C].
    Yaghi C; Baz P; Koussa S; Daniel F; Haddad F; Sayegh R
    Gastroenterol Clin Biol; 2005 May; 29(5):616-7. PubMed ID: 15980766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.